Abstract:Background The Connectivity Map (CMAP) database, an important public data source for drug repositioning, archives gene expression profiles from cancer cell lines treated with and without bioactive small molecules. However, there are only one or two technical replicates for each cell line under one treatment condition. For such small-scale data, current fold-changes-based methods lack statistical control in identifying differentially expressed genes (DEGs) in treated cells. Especially, one-to-one comparison may result in too many drug-irrelevant DEGs due to random experimental factors. To tackle this problem, CMAP adopts a pattern-matching strategy to build “connection” between disease signatures and gene expression changes associated with drug treatments. However, many drug-irrelevant genes may blur the “connection” if all the genes are used instead of pre-selected DEGs induced by drug treatments. Methods We applied OneComp, a customized version of RankComp, to identify DEGs in such small-scale cell line datasets. For a cell line, a list of gene pairs with stable relative expression orderings (REOs) were identified in a large collection of control cell samples measured in different experiments and they formed the background stable REOs. When applying OneComp to a small-scale cell line dataset, the background stable REOs were customized by filtering out the gene pairs with reversal REOs in the control samples of the analyzed dataset. Results In simulated data, the consistency scores of overlapping genes between DEGs identified by OneComp and SAM were all higher than 99%, while the consistency score of the DEGs solely identified by OneComp was 96.85% according to the observed expression difference method. The usefulness of OneComp was exemplified in drug repositioning by identifying phenformin and metformin related genes using small-scale cell line datasets which helped to support them as a potential anti-tumor drug for non-small-cell lung carcinoma, while the pattern-matching strategy adopted by CMAP missed the two connections. The implementation of OneComp is available at https://github.com/pathint/reoa . Conclusions OneComp performed well in both the simulated and real data. It is useful in drug repositioning studies by helping to find hidden “connections” between drugs and diseases.

Identification of Reproducible Drug-Resistance-related Dysregulated Genes in Small-Scale Cancer Cell Line Experiments

De Novo Identification of Expressed Cancer Somatic Mutations from Single-Cell RNA Sequencing Data

Identifying reproducible cancer-associated highly expressed genes with important functional significances using multiple datasets

A Rank-Based Algorithm of Differential Expression Analysis for Small Cell Line Data with Statistical Control.

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Identifying Anti-Cancer Drug Response Related Genes Using an Integrative Analysis of Transcriptomic and Genomic Variations with Cell Line-Based Drug Perturbations.

Statistically Controlled Identification of Differentially Expressed Genes in One-to-one Cell Line Comparisons of the CMAP Database for Drug Repositioning

Apparently low reproducibility of true differential expression discoveries in microarray studies.

Identifying Clinically Relevant Drug Resistance Genes in Drug-Induced Resistant Cancer Cell Lines and Post-Chemotherapy Tissues.

Considering Dependencies Amongst Genes Helps to Adjust the Significance Rank of DEGs

Abstract P58: Utilizing Cancer Vulnerabilities and Dependencies to Explore Cancer Biomarkers by Triangulating Large-Scale Gene Knockout and Drug Response Data

Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection

Reproducibility of the Identification of Genes and Functions Associated with Breast Cancer Metastasis

The Reproducibility of Lists of Differentially Expressed Genes in Microarray Studies

Extracting a Few Functionally Reproducible Biomarkers to Build Robust Subnetwork-Based Classifiers for the Diagnosis of Cancer.

DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer

Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation

Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering

Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours

A drug repurposing method based on inhibition effect on gene regulatory network

Evaluating Reproducibility of Differential Expression Genes Based on Protein-Protein Interactions